Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Net Cash Flow (2016 - 2025)

Aethlon Medical filings provide 15 years of Net Cash Flow readings, the most recent being $688603.0 for Q1 2025.

  • On a quarterly basis, Net Cash Flow rose 127.24% to $688603.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $8.5 million, a 193.83% increase, with the full-year FY2025 number at $81852.0, up 100.9% from a year prior.
  • Net Cash Flow hit $688603.0 in Q1 2025 for Aethlon Medical, down from $2.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $15.3 million in Q2 2021 to a low of -$3.3 million in Q1 2022.
  • Median Net Cash Flow over the past 5 years was -$2.1 million (2022), compared with a mean of $111012.5.
  • Biggest five-year swings in Net Cash Flow: surged 340.52% in 2022 and later tumbled 158.11% in 2023.
  • Aethlon Medical's Net Cash Flow stood at -$2.8 million in 2021, then rose by 24.56% to -$2.1 million in 2022, then decreased by 4.99% to -$2.2 million in 2023, then surged by 190.6% to $2.0 million in 2024, then plummeted by 65.6% to $688603.0 in 2025.
  • The last three reported values for Net Cash Flow were $688603.0 (Q1 2025), $2.0 million (Q4 2024), and $2.2 million (Q3 2024) per Business Quant data.